Test-retest reliability and concurrent validity of the Morrow Assessment of Nausea and Emesis (MANE) for the assessment of cancer chemotherapy-related nausea and vomiting

C. L.M. Carnrike; Phillip J. Brantley; Barbara Bruce; Shaista Faruqui; Frank M. Gresham; Ray R. Buss; Thomas B. Cocke

doi:10.1007/BF00962636

Test-retest reliability and concurrent validity of the Morrow Assessment of Nausea and Emesis (MANE) for the assessment of cancer chemotherapy-related nausea and vomiting

C. L.M. Carnrike, Phillip J. Brantley, Barbara Bruce, Shaista Faruqui, Frank M. Gresham, Ray R. Buss, Thomas B. Cocke

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

The present study evaluated the concurrent validity of two assessment approaches for the measurement of cancer chemotherapy-related nausea and vomiting. The results indicated that the concurrent validity between the Morrow Assessment of Nausea and Emesis (MANE; Morrow, 1984b) and continuous self-monitoring and the reliability on the MANE were moderate. The heterotrait-monomethod and heterotrait-heteromethod matrices demonstrated moderate correlations among the frequency, severity, and duration of anticipatory nausea and vomiting as well as high correlations among the frequency, severity, and duration of posttreatment nausea and vomiting. Additionally, the heterotrait-monomethod matrices show a number of correlations above chance between anticipatory and posttreatment symptoms. The results are discussed in light of future research endeavors.

Original language	English (US)
Pages (from-to)	107-116
Number of pages	10
Journal	Journal of Psychopathology and Behavioral Assessment
Volume	10
Issue number	2
DOIs	https://doi.org/10.1007/BF00962636
State	Published - Jun 1 1988
Externally published	Yes

Keywords

cancer
nausea
reliability
validity
vomiting

ASJC Scopus subject areas

Clinical Psychology

Access to Document

10.1007/BF00962636

Cite this

Carnrike, C. L. M., Brantley, P. J., Bruce, B., Faruqui, S., Gresham, F. M., Buss, R. R., & Cocke, T. B. (1988). Test-retest reliability and concurrent validity of the Morrow Assessment of Nausea and Emesis (MANE) for the assessment of cancer chemotherapy-related nausea and vomiting. Journal of Psychopathology and Behavioral Assessment, 10(2), 107-116. https://doi.org/10.1007/BF00962636

Test-retest reliability and concurrent validity of the Morrow Assessment of Nausea and Emesis (MANE) for the assessment of cancer chemotherapy-related nausea and vomiting. / Carnrike, C. L.M.; Brantley, Phillip J.; Bruce, Barbara et al.
In: Journal of Psychopathology and Behavioral Assessment, Vol. 10, No. 2, 01.06.1988, p. 107-116.

Research output: Contribution to journal › Article › peer-review

Carnrike, CLM, Brantley, PJ, Bruce, B, Faruqui, S, Gresham, FM, Buss, RR & Cocke, TB 1988, 'Test-retest reliability and concurrent validity of the Morrow Assessment of Nausea and Emesis (MANE) for the assessment of cancer chemotherapy-related nausea and vomiting', Journal of Psychopathology and Behavioral Assessment, vol. 10, no. 2, pp. 107-116. https://doi.org/10.1007/BF00962636

@article{41c26448426d474cbf2661a4e9cabf16,

title = "Test-retest reliability and concurrent validity of the Morrow Assessment of Nausea and Emesis (MANE) for the assessment of cancer chemotherapy-related nausea and vomiting",

abstract = "The present study evaluated the concurrent validity of two assessment approaches for the measurement of cancer chemotherapy-related nausea and vomiting. The results indicated that the concurrent validity between the Morrow Assessment of Nausea and Emesis (MANE; Morrow, 1984b) and continuous self-monitoring and the reliability on the MANE were moderate. The heterotrait-monomethod and heterotrait-heteromethod matrices demonstrated moderate correlations among the frequency, severity, and duration of anticipatory nausea and vomiting as well as high correlations among the frequency, severity, and duration of posttreatment nausea and vomiting. Additionally, the heterotrait-monomethod matrices show a number of correlations above chance between anticipatory and posttreatment symptoms. The results are discussed in light of future research endeavors.",

keywords = "cancer, nausea, reliability, validity, vomiting",

author = "Carnrike, {C. L.M.} and Brantley, {Phillip J.} and Barbara Bruce and Shaista Faruqui and Gresham, {Frank M.} and Buss, {Ray R.} and Cocke, {Thomas B.}",

year = "1988",

month = jun,

day = "1",

doi = "10.1007/BF00962636",

language = "English (US)",

volume = "10",

pages = "107--116",

journal = "Journal of Psychopathology and Behavioral Assessment",

issn = "0882-2689",

publisher = "Springer New York",

number = "2",

}

TY - JOUR

T1 - Test-retest reliability and concurrent validity of the Morrow Assessment of Nausea and Emesis (MANE) for the assessment of cancer chemotherapy-related nausea and vomiting

AU - Carnrike, C. L.M.

AU - Brantley, Phillip J.

AU - Bruce, Barbara

AU - Faruqui, Shaista

AU - Gresham, Frank M.

AU - Buss, Ray R.

AU - Cocke, Thomas B.

PY - 1988/6/1

Y1 - 1988/6/1

N2 - The present study evaluated the concurrent validity of two assessment approaches for the measurement of cancer chemotherapy-related nausea and vomiting. The results indicated that the concurrent validity between the Morrow Assessment of Nausea and Emesis (MANE; Morrow, 1984b) and continuous self-monitoring and the reliability on the MANE were moderate. The heterotrait-monomethod and heterotrait-heteromethod matrices demonstrated moderate correlations among the frequency, severity, and duration of anticipatory nausea and vomiting as well as high correlations among the frequency, severity, and duration of posttreatment nausea and vomiting. Additionally, the heterotrait-monomethod matrices show a number of correlations above chance between anticipatory and posttreatment symptoms. The results are discussed in light of future research endeavors.

AB - The present study evaluated the concurrent validity of two assessment approaches for the measurement of cancer chemotherapy-related nausea and vomiting. The results indicated that the concurrent validity between the Morrow Assessment of Nausea and Emesis (MANE; Morrow, 1984b) and continuous self-monitoring and the reliability on the MANE were moderate. The heterotrait-monomethod and heterotrait-heteromethod matrices demonstrated moderate correlations among the frequency, severity, and duration of anticipatory nausea and vomiting as well as high correlations among the frequency, severity, and duration of posttreatment nausea and vomiting. Additionally, the heterotrait-monomethod matrices show a number of correlations above chance between anticipatory and posttreatment symptoms. The results are discussed in light of future research endeavors.

KW - cancer

KW - nausea

KW - reliability

KW - validity

KW - vomiting

UR - http://www.scopus.com/inward/record.url?scp=0003699260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0003699260&partnerID=8YFLogxK

U2 - 10.1007/BF00962636

DO - 10.1007/BF00962636

M3 - Article

AN - SCOPUS:0003699260

SN - 0882-2689

VL - 10

SP - 107

EP - 116

JO - Journal of Psychopathology and Behavioral Assessment

JF - Journal of Psychopathology and Behavioral Assessment

IS - 2

ER -

Test-retest reliability and concurrent validity of the Morrow Assessment of Nausea and Emesis (MANE) for the assessment of cancer chemotherapy-related nausea and vomiting

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this